Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

BACKGROUND: To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular carcinoma (HCC) patients, and to explore the range...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yanqiao, Cao, Yanyan, Ma, Hong, Kan, Xuefeng, Zhou, Chen, Liu, Jiacheng, Shi, Qin, Feng, Gansheng, Xiong, Bin, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805486/
https://www.ncbi.nlm.nih.gov/pubmed/31640620
http://dx.doi.org/10.1186/s12885-019-6237-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805486/
https://www.ncbi.nlm.nih.gov/pubmed/31640620
http://dx.doi.org/10.1186/s12885-019-6237-5

Ejemplares similares